Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies
Open Access
- 20 November 2020
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 7 (12) , 2450-2460
Abstract
Objective: Lewy body (LB) synucleinopathies such as Parkinson’s disease (PD) entail profound cardiac norepinephrine deficiency. The status of sympathetic noradrenergic innervation at other extracranial sites has been unclear. Although in vivo neuroimaging studies have indicated a cardioselective noradrenergic lesion, no previous study has surveyed peripheral organs for norepinephrine contents in LB diseases. We reviewed 18F‐dopamine (18F‐DA) positron emission tomographic images and postmortem neurochemical data across several body organs of controls and patients with the LB synucleinopathies PD and pure autonomic failure (PAF) and the non‐LB synucleinopathy multiple system atrophy (MSA).Methods: 18F‐DA–derived radioactivity in the heart, liver, spleen, pancreas, stomach, kidneys, thyroid, and submandibular glands were analyzed from 145 patients with LB synucleinopathies (112 PD, 33 PAF), 74 controls, and 85 MSA patients. In largely separate cohorts, postmortem tissue norepinephrine data were reviewed for heart, liver, spleen, pancreas, kidney, thyroid, submandibular gland, and sympathetic ganglion tissue from 38 PD, 2 PAF, and 5 MSA patients and 35 controls.Results: Interventricular septal 18F‐DA–derived radioactivity was decreased in the LB synucleinopathy group compared to the control and MSA groups (P < 0.0001 each). The LB and non‐LB groups did not differ in liver, spleen, pancreas, stomach, or kidney 18F‐DA–derived radioactivity. The LB synucleinopathy group had markedly decreased apical myocardial norepinephrine, but normal tissue norepinephrine in other organs. The MSA group had normal tissue norepinephrine in all examined organs.Interpretation: By in vivo sympathetic neuroimaging and postmortem neurochemistry peripheral noradrenergic deficiency in LB synucleinopathies is cardioselective. MSA does not involve peripheral noradrenergic deficiency.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (18N0140, 03N0004)
- Health Research
- Clinical Center
This publication has 54 references indexed in Scilit:
- Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson modelProceedings of the National Academy of Sciences, 2013
- Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseasesJournal of Clinical Investigation, 2011
- MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysisClinical Autonomic Research, 2011
- Neurogenic Orthostatic HypotensionCirculation, 2009
- Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophyParkinsonism & Related Disorders, 2008
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- Pathogenesis of parkinson's disease: dopamine, vesicles and α-synucleinNature Reviews Neuroscience, 2002
- α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophyNeuroscience Letters, 1998
- Sympathetic Cardioneuropathy in DysautonomiasNew England Journal of Medicine, 1997
- SELECTIVE α2RECEPTOR BLOCKADE FACILITATES THE INSULIN RESPONSE TO ADRENALINE BUT NOT TO GLUCOSE IN MANClinical Endocrinology, 1985